Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comprehensive analysis of facial skin microbiome

ABSTRACT: Spermidine-induced recovery of human skin structure and barrier function by skin microbiome

PROVIDER: PRJEB34022 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3485810_1.fastq.gz	Fastqsanger.gz
	ERR3485810_2.fastq.gz	Fastqsanger.gz
	ERR3485820_1.fastq.gz	Fastqsanger.gz
	ERR3485820_2.fastq.gz	Fastqsanger.gz
	ERR3485830_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 176

Similar Datasets

Comprehensive transcriptional analysis of pig facial skin development

Project description:To study the development of pig facial skin after birth, we use the facial skin tissues of healthy Chenghua sows as experimental materials. we then performed gene expression profiling analysis using data obtained from RNA-seq of pig facial skin tissues at four time points.

2023-05-10 | GSE231573 | GEO

Comprehensive analysis of lipid metabolism-related enzymes including ceramide in skin of psoriasis patients

Project description:Ceramide is an important lipid in skin barrier function. Psoriasis is a chronic inflammatory skin disease, and the skin barrier function has disturbed. Furthermore, the balance of each ceramide species in stratum corneum is disrupted in psoriatic skin. However, it involved remains unclear what detailed mechanism ceramide species changed in psoriatic skin lesion. We comprehensively investigated lipid metabolism including ceramide in skin of psoriasis patients by DNA microarray analysis. The expression level of PNPLA1 gene involved in acylceramide synthesis which is epidermis-specific ceramide species essential for skin barrier function was decreased in psoriatic skin. In contrast, the expression level of lipid metabolism-related enzymes gene including ceramide were increased in psoriatic skin. Consequently, the acylceramide synthesis was decreased in skin of psoriasis patients, suggesting that increased biosynthesis of other sphingolipids to supplement the function of acylceramide may cause the pathology of psoriasis.

2024-03-16 | GSE168640 | GEO

Project description:Profiling the skin microbiota composition from the face of healthy women. Exploring the differences between three age groups and between dry skin and not dry.

2023-02-24 | GSE225848 | GEO

Title: Demographic Factors Predictive of Skin Barrier Function in a Large Population-Based Study

Project description:The skin has a vital role in homeostasis, but there are limited and conflicting data on factors associated with skin barrier function. We evaluated the relationship between participant characteristics and four barrier function measures in a diverse population-based sample of 286 participants ages 32-97 in the Baltimore Longitudinal Study of Aging (BLSA), a well-characterized cohort of healthy aging. Multivariable analysis indicated older age, female sex, Black race/ethnicity, and higher BMI were associated with at least one measure of better barrier function: older age was associated with better dynamic barrier function (beta=-0.141, p=0.034) and barrier permeability (beta=-0.158, p=0.018); female participants had superior dynamic barrier function (beta=0.164, p=0.027) and increased barrier recovery (beta=-0.239, p=0.001); black participants also had better dynamic barrier function (beta=-0.200, p=0.006) and higher barrier integrity (beta=0.256, p<0.001); and higher BMI was associated with better barrier integrity (beta=0.131, p=0.033). Protein expression from tape strips analyzed by mass spectrometry among a sub-sample of 20 participants showed that protein families linked to barrier composition and insult response were higher among participants with above-median barrier function (p<0.01). Our results provide a framework for future research on epidermal barrier function and suggest additional measures are needed to differentiate age-associated barrier decline.

2025-05-08 | MSV000097834 | MassIVE

Hair follicles modulate skin barrier function

Project description:Hair follicles modulate skin barrier function

| PRJNA1072231 | ENA

Facial Skin Biophysical Multi-Parameter and Microbiome-Based Korean Skin Cutoype (KSC) Determination

Project description:In this study, we conducted an integrated analysis of skin measurements, clinical BSTI surveys, and the skin microbiome of 950 Korean subjects to examine the ideal skin microbiome-biophysical association. By utilizing four skin biophysical parameters, we identified four distinct Korean Skin Cutotypes (KSCs) and categorized the subjects into three aging groups based on their age distribution. We established strong connections between 15 core genera and the four KSC types within the three aging groups, revealing three prominent clusters of the facial skin microbiome. Together with skin microbiome variations, skin tone/elasticity distinguishes aging groups while oiliness/hydration distinguishes individual differences within aging groups. Our study provides prospective reality data for customized skin care based on the microbiome environment of each skin type.

| EGAS00001007334 | EGA

skin metagenome

Project description:Structure-Function of Bullfrog Skin Microbiota: an Experiment

| PRJNA293463 | ENA

Comprehensive transcriptional analysis of pig facial skin development

Project description:Comprehensive transcriptional analysis of pig facial skin development

| PRJNA966966 | ENA

Targeted therapies restore skin barrier function and associated proteomics in atopic dermatitis

Project description:Background: Atopic dermatitis (AD) is characterized by skin barrier dysfunction. The impact of targeted therapies on skin barrier function and associated barrier protein changes remains not fully identified. Objective: To investigate the skin barrier function and proteomics in AD before and after different targeted therapies. Method: 15 healthy controls and 29 adult patients with moderate-to-severe AD were enrolled. AD patients were randomized into two groups. One group received dupilumab (N = 14) and the other received abrocitinib (N = 15). Clinical assessments and skin barrier parameters (transepidermal water loss [TEWL] and hydration) were measured at baseline, 4 weeks, and 12 weeks of treatment. Skin tape strips were collected for four-dimensional data-independent acquisition-based proteomics. Results: Both therapies improved skin barrier function, with abrocitinib showing greater effects on decreasing TEWL in the non-lesional skin. The proteomic analysis identified 1237 lesional and 785 non-lesional differentially expressed proteins (DEPs) between AD patients and healthy controls, especially in pathways related to ceramide metabolism, neurobiology, and keratinocyte biology. Treatment with abrocitinib resulted in more DEPs and significantly upregulated proteins associated with the epidermal barrier while downregulating immunological and itch-related proteins. It also increased key barrier proteins (filaggrin-2 and loricrin) in lesional skin, which was not shown in the dupilumab group. Both treatments regulated specific proteins in non-lesional skin, such as grancalcin and phospholipase D3. Conclusion: The study suggests that both targeted therapies improve the skin barrier function in AD, but they have different effects on barrier proteins, with abrocitinib having stronger effects.

2025-04-19 | PXD055561 | Pride

A widespread cell atlas of pig skin from embryonic development to postnatal aging

Project description:Skin is the largest barrier organ with complex structure and function. We investigated the transcriptional dynamics of pig skin during development and aging at single-cell resolution. Using single-cell RNA sequencing, we profiled the transcriptomes of 443,529 skin cells derived from 30 individuals of 10 developmental time points staged between 56 days of gestation and 7 years old. Our analysis identified the dynamic changes in the cellular transcriptional profile of eight skin cell types at different developmental stages, exhibiting time-dependent skin cell heterogeneity.

2025-08-10 | GSE244532 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data